Home » Analyst Articles – US
Limbach (NASDAQ:LMB) Price Target Cut to $90.00 by Analysts at JPMorgan Chase & Co.
Limbach (NASDAQ:LMB – Free Report) had its price objective decreased by JPMorgan Chase & Co. from $100.00 to $90.00 in a research note published on Thursday,Benzinga reports. JPMorgan Chase & Co. currently has a neutral... More of this article »
Lucid Diagnostics (NASDAQ:LUCD) Given Buy Rating at Needham & Company LLC
Needham & Company LLC reiterated their buy rating on shares of Lucid Diagnostics (NASDAQ:LUCD – Free Report) in a research report released on Thursday,Benzinga reports. Needham & Company LLC currently has a $3.00 price... More of this article »
Pacira BioSciences (NASDAQ:PCRX) Given New $25.00 Price Target at Barclays
Pacira BioSciences (NASDAQ:PCRX – Free Report) had its target price reduced by Barclays from $27.00 to $25.00 in a research note issued to investors on Thursday morning,Benzinga reports. They currently have an equal weight rating... More of this article »
Nkarta (NASDAQ:NKTX) Price Target Raised to $11.00 at Needham & Company LLC
Nkarta (NASDAQ:NKTX – Free Report) had its price objective upped by Needham & Company LLC from $10.00 to $11.00 in a report issued on Thursday morning,Benzinga reports. Needham & Company LLC currently has a buy rating... More of this article »
KalVista Pharmaceuticals (NASDAQ:KALV) Given New $28.00 Price Target at Citizens Jmp
KalVista Pharmaceuticals (NASDAQ:KALV – Free Report) had its price objective lowered by Citizens Jmp from $29.00 to $28.00 in a research report released on Thursday morning,Benzinga reports. The firm currently has a market outperform... More of this article »
LENZ Therapeutics (NASDAQ:LENZ) Price Target Lowered to $26.00 at Citigroup
LENZ Therapeutics (NASDAQ:LENZ – Free Report) had its price target reduced by Citigroup from $52.00 to $26.00 in a research report report published on Thursday,Benzinga reports. They currently have a buy rating on the stock. Several... More of this article »
BMO Capital Markets Issues Positive Forecast for Laureate Education (NASDAQ:LAUR) Stock Price
Laureate Education (NASDAQ:LAUR – Free Report) had its target price increased by BMO Capital Markets from $40.00 to $43.00 in a report published on Thursday morning,Benzinga reports. They currently have an outperform rating on... More of this article »
Ondas (NASDAQ:ONDS) Price Target Raised to $18.00 at Northland Securities
Ondas (NASDAQ:ONDS – Free Report) had its price target hoisted by Northland Securities from $16.00 to $18.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has an outperform rating... More of this article »
Palisade Bio (NASDAQ:PALI) Now Covered by Analysts at HC Wainwright
HC Wainwright initiated coverage on shares of Palisade Bio (NASDAQ:PALI – Free Report) in a report released on Thursday morning, Marketbeat reports. The brokerage issued a buy rating and a $7.00 target price on the stock. PALI... More of this article »
Organogenesis (NASDAQ:ORGO) Receives “Buy” Rating from BTIG Research
BTIG Research reissued their buy rating on shares of Organogenesis (NASDAQ:ORGO – Free Report) in a report released on Thursday morning,Benzinga reports. BTIG Research currently has a $8.00 price objective on the stock. Several... More of this article »
Paysign’s (PAYS) “Buy” Rating Reaffirmed at DA Davidson
DA Davidson reiterated their buy rating on shares of Paysign (NASDAQ:PAYS – Free Report) in a report issued on Thursday,Benzinga reports. The brokerage currently has a $9.00 price target on the stock. Several other equities... More of this article »
Principal Financial Group (NASDAQ:PFG) Given Market Perform Rating at Keefe, Bruyette & Woods
Keefe, Bruyette & Woods restated their market perform rating on shares of Principal Financial Group (NASDAQ:PFG – Free Report) in a research note released on Thursday morning,Benzinga reports. Keefe, Bruyette & Woods... More of this article »
Wingstop (NASDAQ:WING) Given New $250.00 Price Target at Stifel Nicolaus
Wingstop (NASDAQ:WING – Free Report) had its target price cut by Stifel Nicolaus from $325.00 to $250.00 in a research note published on Thursday,Benzinga reports. They currently have a buy rating on the restaurant operator’s... More of this article »
Sarepta Therapeutics’ (SRPT) Underperform Rating Reaffirmed at Needham & Company LLC
Needham & Company LLC reiterated their underperform rating on shares of Sarepta Therapeutics (NASDAQ:SRPT – Free Report) in a research report sent to investors on Thursday,Benzinga reports. Other research analysts have... More of this article »
Tower Semiconductor (NASDAQ:TSEM) Price Target Raised to $230.00 at Benchmark
Tower Semiconductor (NASDAQ:TSEM – Free Report) had its target price increased by Benchmark from $165.00 to $230.00 in a research note published on Thursday,Benzinga reports. The brokerage currently has a buy rating on the semiconductor... More of this article »
Wells Fargo & Company Issues Positive Forecast for Sabra Healthcare REIT (NASDAQ:SBRA) Stock Price
Sabra Healthcare REIT (NASDAQ:SBRA – Free Report) had its price target hoisted by Wells Fargo & Company from $21.00 to $22.00 in a research report sent to investors on Thursday,Benzinga reports. The brokerage currently has... More of this article »
Qualcomm (NASDAQ:QCOM) Receives “Market Perform” Rating from Sanford C. Bernstein
Sanford C. Bernstein restated their market perform rating on shares of Qualcomm (NASDAQ:QCOM – Free Report) in a report published on Thursday morning, Marketbeat reports. Sanford C. Bernstein currently has a $140.00 price objective... More of this article »
WeRide (NASDAQ:WRD) Now Covered by BNP Paribas Exane
BNP Paribas Exane assumed coverage on shares of WeRide (NASDAQ:WRD – Free Report) in a research report report published on Thursday morning, MarketBeat.com reports. The firm issued an outperform rating and a $11.00 price objective... More of this article »
Verra Mobility (NASDAQ:VRRM) Given New $19.00 Price Target at JPMorgan Chase & Co.
Verra Mobility (NASDAQ:VRRM – Free Report) had its price objective trimmed by JPMorgan Chase & Co. from $21.00 to $19.00 in a research note issued to investors on Thursday morning,Benzinga reports. The firm currently has... More of this article »
Viking Therapeutics (NASDAQ:VKTX) Coverage Initiated by Analysts at Wolfe Research
Wolfe Research assumed coverage on shares of Viking Therapeutics (NASDAQ:VKTX – Free Report) in a report released on Thursday, Marketbeat.com reports. The brokerage issued a peer perform rating on the biotechnology company’s... More of this article »
Real Brokerage (NASDAQ:REAX) Now Covered by Benchmark
Benchmark started coverage on shares of Real Brokerage (NASDAQ:REAX – Free Report) in a research note released on Thursday, MarketBeat reports. The firm issued a buy rating and a $5.50 price target on the stock. Several other... More of this article »
Citigroup Issues Positive Forecast for Sarepta Therapeutics (NASDAQ:SRPT) Stock Price
Sarepta Therapeutics (NASDAQ:SRPT – Free Report) had its price objective hoisted by Citigroup from $9.00 to $13.00 in a research note published on Thursday,Benzinga reports. They currently have a sell rating on the biotechnology... More of this article »
Sagimet Biosciences (NASDAQ:SGMT) Now Covered by Rodman & Renshaw
Rodman & Renshaw started coverage on shares of Sagimet Biosciences (NASDAQ:SGMT – Free Report) in a report issued on Thursday, MarketBeat Ratings reports. The brokerage issued a buy rating and a $28.00 price target on the... More of this article »
Ross Stores (NASDAQ:ROST) Receives “Outperform” Rating from Telsey Advisory Group
Telsey Advisory Group restated their outperform rating on shares of Ross Stores (NASDAQ:ROST – Free Report) in a research note published on Thursday,Benzinga reports. They currently have a $240.00 price objective on the apparel... More of this article »
ADMA Biologics (NASDAQ:ADMA) Given “Neutral” Rating at Cantor Fitzgerald
Cantor Fitzgerald reaffirmed their neutral rating on shares of ADMA Biologics (NASDAQ:ADMA – Free Report) in a research report released on Thursday morning, MarketBeat reports. Other equities research analysts have also issued... More of this article »
Acumen Pharmaceuticals (NASDAQ:ABOS) Given “Buy” Rating at BTIG Research
BTIG Research reiterated their buy rating on shares of Acumen Pharmaceuticals (NASDAQ:ABOS – Free Report) in a research note published on Thursday morning,Benzinga reports. The brokerage currently has a $8.00 price objective... More of this article »
Airbnb (NASDAQ:ABNB) Rating Increased to Hold at Truist Financial
Truist Financial upgraded shares of Airbnb (NASDAQ:ABNB – Free Report) from a sell rating to a hold rating in a report released on Thursday morning, Marketbeat.com reports. The brokerage currently has $129.00 price objective... More of this article »
Adobe (NASDAQ:ADBE) Now Covered by William Blair
William Blair assumed coverage on shares of Adobe (NASDAQ:ADBE – Free Report) in a report released on Thursday morning, Marketbeat Ratings reports. The brokerage issued a market perform rating on the software company’s... More of this article »
NSRX (NYSEAMERICAN:NSRX) Given New $18.00 Price Target at Citizens Jmp
NSRX (NYSEAMERICAN:NSRX – Free Report) had its price target cut by Citizens Jmp from $19.00 to $18.00 in a report issued on Thursday,Benzinga reports. They currently have a market outperform rating on the stock. NSRX Price Performance NSRX... More of this article »
Bank of America (NYSE:BAC) Now Covered by Jefferies Financial Group
Jefferies Financial Group began coverage on shares of Bank of America (NYSE:BAC) in a report issued on Thursday morning, MarketBeat reports. The firm issued a buy rating and a $60.00 price target on the financial services provider’s... More of this article »
VolitionRX’s (VNRX) “Buy” Rating Reaffirmed at D. Boral Capital
D. Boral Capital reiterated their buy rating on shares of VolitionRX (NYSEAMERICAN:VNRX – Free Report) in a research report report published on Thursday morning,Benzinga reports. D. Boral Capital currently has a $3.00 price... More of this article »
Aflac (NYSE:AFL) Given “Market Perform” Rating at Keefe, Bruyette & Woods
Keefe, Bruyette & Woods reaffirmed their market perform rating on shares of Aflac (NYSE:AFL – Free Report) in a research note issued to investors on Thursday morning,Benzinga reports. They currently have a $113.00 price... More of this article »
AES (NYSE:AES) Downgraded to Hold Rating by Argus
Argus cut shares of AES (NYSE:AES – Free Report) from a buy rating to a hold rating in a research report released on Thursday, Marketbeat.com reports. AES has been the subject of a number of other research reports. Jefferies... More of this article »
American Eagle Outfitters (NYSE:AEO) Coverage Initiated by Analysts at Needham & Company LLC
Needham & Company LLC started coverage on shares of American Eagle Outfitters (NYSE:AEO – Free Report) in a report published on Thursday, MarketBeat.com reports. The firm issued a hold rating on the apparel retailer’s... More of this article »
Apple Hospitality REIT (NYSE:APLE) Now Covered by Analysts at LADENBURG THALM/SH SH
LADENBURG THALM/SH SH started coverage on shares of Apple Hospitality REIT (NYSE:APLE – Free Report) in a research report released on Thursday, MarketBeat reports. The brokerage issued a neutral rating and a $13.00 price target... More of this article »
Contango ORE (NYSEAMERICAN:CTGO) Now Covered by Analysts at Canaccord Genuity Group
Canaccord Genuity Group started coverage on shares of Contango ORE (NYSEAMERICAN:CTGO – Free Report) in a report published on Thursday, Marketbeat reports. The firm issued a buy rating and a $32.00 target price on the stock. Separately,... More of this article »
American Assets Trust (NYSE:AAT) Price Target Raised to $18.00 at Morgan Stanley
American Assets Trust (NYSE:AAT – Free Report) had its price target raised by Morgan Stanley from $17.00 to $18.00 in a research note released on Thursday morning,Benzinga reports. The firm currently has an underweight rating... More of this article »
Abercrombie & Fitch (NYSE:ANF) Now Covered by Needham & Company LLC
Needham & Company LLC assumed coverage on shares of Abercrombie & Fitch (NYSE:ANF – Free Report) in a research report released on Thursday, MarketBeat reports. The firm issued a buy rating and a $108.00 price objective... More of this article »
Chewy’s (CHWY) “Buy” Rating Reaffirmed at Guggenheim
Guggenheim reiterated their buy rating on shares of Chewy (NYSE:CHWY – Free Report) in a report released on Thursday,Benzinga reports. They currently have a $45.00 price target on the stock. CHWY has been the topic of a number... More of this article »
Chewy (NYSE:CHWY) Price Target Cut to $46.00 by Analysts at The Goldman Sachs Group
Chewy (NYSE:CHWY – Free Report) had its target price trimmed by The Goldman Sachs Group from $52.00 to $46.00 in a research note issued to investors on Thursday,Benzinga reports. The firm currently has a buy rating on the stock. A... More of this article »
Citigroup (NYSE:C) Coverage Initiated by Analysts at Jefferies Financial Group
Jefferies Financial Group started coverage on shares of Citigroup (NYSE:C – Free Report) in a research report report published on Thursday morning, Marketbeat reports. The firm issued a buy rating and a $135.00 price objective... More of this article »
Choice Hotels International (NYSE:CHH) Price Target Raised to $129.00 at Truist Financial
Choice Hotels International (NYSE:CHH – Free Report) had its price target increased by Truist Financial from $126.00 to $129.00 in a research note issued to investors on Thursday,Benzinga reports. They currently have a buy rating... More of this article »
Braskem (NYSE:BAK) Downgraded to “Underperform” Rating by Bank of America
Bank of America lowered shares of Braskem (NYSE:BAK – Free Report) from a neutral rating to an underperform rating in a report issued on Thursday morning, MarketBeat.com reports. The brokerage currently has $2.80 target price... More of this article »
TD Cowen Issues Positive Forecast for Chewy (NYSE:CHWY) Stock Price
Chewy (NYSE:CHWY – Free Report) had its price objective lifted by TD Cowen from $39.00 to $42.00 in a research note issued to investors on Thursday morning,Benzinga reports. They currently have a buy rating on the stock. CHWY... More of this article »
Chewy (NYSE:CHWY) Given New $45.00 Price Target at Citizens Jmp
Chewy (NYSE:CHWY – Free Report) had its price objective lowered by Citizens Jmp from $48.00 to $45.00 in a research report report published on Thursday morning,Benzinga reports. Citizens Jmp currently has a market outperform... More of this article »
Chewy (NYSE:CHWY) Given New $36.00 Price Target at Wedbush
Chewy (NYSE:CHWY – Free Report) had its target price reduced by Wedbush from $42.00 to $36.00 in a research report report published on Thursday morning,Benzinga reports. They currently have an outperform rating on the stock. Several... More of this article »
CAVA Group (NYSE:CAVA) Coverage Initiated by Analysts at Guggenheim
Guggenheim started coverage on shares of CAVA Group (NYSE:CAVA – Free Report) in a research note published on Thursday, Marketbeat reports. The firm issued a buy rating and a $100.00 price objective on the stock. A number of... More of this article »
UBS Group Issues Positive Forecast for CF Industries (NYSE:CF) Stock Price
CF Industries (NYSE:CF – Free Report) had its price objective lifted by UBS Group from $97.00 to $140.00 in a research report sent to investors on Thursday morning,Benzinga reports. UBS Group currently has a neutral rating on... More of this article »